Century Therapeutics, Inc.IPSCNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-9.8%
5Y CAGR+24.7%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-9.8%/yr
Annual compound
5Y CAGR
+24.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$23.38M-29.5%
2024$33.16M-4.5%
2023$34.71M+8.9%
2022$31.86M+117.4%
2021$14.65M+89.3%
2020$7.74M+40.3%
2019$5.52M-